This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Mesa Labs Acquires The Biological Indicators Business Of Apex Laboratories, Inc.

LAKEWOOD, Colo., Dec. 21, 2010 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB), a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company.  The acquisition of the Apex business is expected to be immediately accretive to Mesa's earnings per share.

Apex Labs is the worldwide leader in sales of biological indicators (BI) for hydrogen peroxide vapor systems that operate at ambient pressures.  These processes are commonly used for decontamination of glove boxes, aseptic processing lines, and  entire rooms in the pharmaceutical, medical device, healthcare, and food industries.  Biological indicators are used to ensure that the conditions in enclosures are appropriate to achieve the proper level of decontamination.  Apex pioneered this market in the mid-1990's with the introduction of a BI using a small stainless steel disk as the bacterial spore carrier.  As the market grew, the Apex disk became the standard in the industry for quality control applications.  

Mesa Labs was founded in 1982 and manufactures instruments and disposable products utilized in connection with industrial applications and healthcare.  Products include DataTrace data loggers and Torqo torque testers for quality control applications in pharmaceutical, food, and medical device manufacturing; Medical meters used for quality control in dialysis clinics; and Biological Indicators used for quality control of sterilization processes in hospitals and dental offices, along with pharmaceutical and medical device companies.

In this transaction, Apex is selling to Mesa Labs the assets associated with their hydrogen peroxide BI products and services.  Following a brief transition period, Mesa will be relocating the Apex business to its newly acquired SGM Biotech division in Bozeman, Montana.

"We are delighted to announce the addition of the Apex line of biological indicators to Mesa's BI businesses," said John J. Sullivan, President and CEO of Mesa Labs.  "The Apex hydrogen peroxide BI products complement Mesa Labs' existing line of biological indicators.  Apex has captured the major share of this market, due to the excellent customer service and performance characteristics of their hydrogen peroxide BI.  Now, with the addition of the Apex BI, Mesa will be able to capitalize on the opportunities in this rapidly growing market."

"I am pleased to find a quality organization like Mesa to continue the Apex BI product line," said Joseph P. Dalmasso, President of Apex.  "I respect the technical expertise and excellent customer support that resides in Mesa's organization, and I am confident the many loyal customers Apex developed over the past thirteen years will be well served by Mesa's staff."

This news release contains forward-looking statements which involve risks and uncertainties.  The Company's actual results could differ materially from those in any such forward-looking statements.  Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2010 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.

www.mesalabs.com

SOURCE Mesa Laboratories, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs